Multiple Manufacturers

CABERGOLINE

Manufacturer:

Multiple Manufacturers

Cabergoline HCPCS:

J8515

HCPCS Code Descriptor:

Cabergoline, oral, 0.25 mg

Category:

J Code

Cabergoline NDCs:

00378-2800-26, 00093-5420-88, 59762-1005-01, 50742-0118-08, 23155-0823-73

Primary Type:

Parkinson's disease, Hyperprolactinemia

Generic/Specialty Status:

Multi-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00378-2800-26

About Cabergoline:

CABERGOLINE is a Parkinson's disease, Hyperprolactinemia drug manufactured by MYLAN and administered via the Oral route of administration. The J Code: J8515 is aligned to the drug CABERGOLINE.

ACCESS PRICING AND MORE BY REGISTERING

J8515 Added Date:

January 1, 2006

J8515 Effective Date:

January 1, 2006

J8515 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cabergoline billing and coding information.
Our team did not identify a source for Cabergoline patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for CABERGOLINE
Our team has not yet identified a source of side effects information for CABERGOLINE. Please check back in a few weeks.